About ARCH Hawaii Symposium
Overview
ARCH Hawaii 2026 emphasizes real-world, evidence-based strategies with sessions covering complex PCI, lifetime structural heart management, imaging integration, pulmonary embolism and DVT care, and state-of-the-art pharmacologic updates.
Integrating live global case transmissions, cutting-edge technologies, disruptive innovations, and expanded content for general cardiology practitioners, attendees will gain practical insights, expert tips, and innovative therapeutic approaches designed to elevate patient care and outcomes.
This year, ARCH Hawaii introduces dedicated sessions on general cardiology topics—hypertension, heart failure, atrial fibrillation, GLP-1/SGLT2 therapies, and dyslipidemia management—broadening the scope for a wider audience.
Conference Highlights
- Educational sessions dedicated to hot topics in cardiology including the expanding role of Artificial Intelligence in the treatment of cardiovascular disease
- Management of aortic, mitral and tricuspid disease, including live-case demonstration
- Avoiding and treating serious complications of coronary and structural interventions
- Discuss controversies and interventional dilemmas / focus on procedural strategies for success
- Review the use and impact of adjunctive imaging modalities, IVUS, OCT and CT angiography and review current data on new technology to diagnose coronary artery disease
- Learn tips and tricks for coronary and structural interventions in technically difficult and high-risk subsets
- Define the use of percutaneous left ventricular assist devices (LVAD) in complex, high risk cases
- Multiple Live-Cases from locations across the globe
- State-of-the-art talks from nationally recognized experts
- Real time networking with colleagues and course faculty
- Annual Fellows Course
- MOC credits available for attendees
